NCT04594551View on ClinicalTrials.gov

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

October 11, 2020

Primary Completion Date

June 23, 2021

Study Completion Date

June 23, 2021

Conditions
Rabies (Healthy Volunteers)
Interventions
BIOLOGICAL

Purified vero rabies vaccine - serum free

Pharmaceutical form:freeze-dried - Route of administration: intramuscular

BIOLOGICAL

Purified inactivated rabies vaccine

Pharmaceutical form:freeze-dried - Route of administration: intramuscular

BIOLOGICAL

Human rabies immunoglobulins

Pharmaceutical form:liquid/solution in 2 mL vials - Route of administration: intramuscular

Trial Locations (3)

10330

Investigational site number 7640002, Bangkok

10400

Investigational site number 7640001, Bangkok

10700

Investigational site number 7640003, Bangkok

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT04594551 - Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland | Biotech Hunter | Biotech Hunter